Answer
Etodolac reduces inflammation by inhibiting prostaglandin synthesis, preferentially inhibiting inflammation-associated COX-2 over COX-1; the clinical benefit of this selectivity has not been proven.
Sources for this answer
- Lodine SRAlmirall Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 12Document updated
Sources checked